Related Experiment Video
Updated: Apr 17, 2026

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues
Published on: June 16, 2018
Sweets for a bitter end: lung cancer cell-surface protein glycosylation mediates metastatic colonization
Anna Arnal-Estapé1, Don X Nguyen2
1Department of Pathology, Yale University School of Medicine, New Haven, Connecticut.
Abstract:
Glycosylation is one of the most predominant forms of cell-surface protein modifications, yet its deregulation in cancer and contribution to tumor microenvironment interactions remain poorly understood. In this issue of Cancer Discovery, Reticker-Flynn and Bhatia characterize an enzymatic switch in lung cancer cells that triggers aberrant surface protein glycosylation patterns, adhesion to lectins on the surface of inflammatory cells, and subsequent metastatic colonization of the liver.
Insights
Aberrant glycosylation in lung cancer cells promotes metastasis. This study identifies an enzymatic switch driving altered cell surface proteins, leading to inflammatory cell adhesion and liver colonization.
Area of Science:
- Biochemistry
- Cancer Biology
- Cell Biology
Background:
- Glycosylation is a major post-translational modification of cell surface proteins.
- Dysregulated glycosylation is implicated in cancer progression and the tumor microenvironment.
- The precise mechanisms linking aberrant glycosylation to metastasis are not fully understood.
Purpose of the Study:
- To investigate the role of aberrant glycosylation in lung cancer metastasis.
- To identify the enzymatic regulators of cell surface glycosylation changes in cancer.
- To elucidate how altered glycosylation impacts interactions with the tumor microenvironment.
Main Methods:
- Characterization of enzymatic activity in lung cancer cells.
- Analysis of cell surface protein glycosylation patterns.
- Assessment of cancer cell adhesion to inflammatory cells.
- In vivo models to study metastatic colonization.
Main Results:
- Identification of a specific enzymatic switch triggering aberrant glycosylation in lung cancer.
- Demonstration of altered lectin binding on cancer cells due to aberrant glycosylation.
- Evidence linking these changes to increased adhesion with inflammatory cells.
- Confirmation of enhanced liver metastatic colonization.
Conclusions:
- Aberrant glycosylation driven by an enzymatic switch is a key mechanism in lung cancer metastasis.
- Altered cell surface glycans facilitate interactions with inflammatory cells, promoting metastasis.
- Targeting this glycosylation pathway may offer therapeutic strategies for lung cancer.
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Selectins
Cancer Cell Migration through Invadopodia
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

